期刊文献+

细支气管肺泡癌临床特点分析(附68例分析) 被引量:1

Clinical features of bronchioloalveolar carcinoma (68 cases)
暂未订购
导出
摘要 目的分析细支气管肺泡癌的临床特点,对临床诊断治疗起到指导。方法对所有患者进行3年及以上随访,统计患者性别、年龄、影像学表现、病理结果,分析不同临床分期所占比例,影像学检查分类以及不同性别间患者的3年生存率。结果临床分期Ⅱ期最多,为20例(29.4%),IV期最少,影像学孤立结节型77.9%、多结节型8.9%,浸润性肺炎型13.2%,不同性别间生存率差异无统计学意义(P〉0.05)。结论细支气管肺泡癌好发于女性和不吸烟者,早期诊断困难,预后1年生存率较高。 Objective To analyze the clinical bronchioloalveolar careinoma features, so to guide the clinical diagnosis and treatment. Methods All patients were followed up for 3 years and over, statistics sex, age, imaging, pathology results, the proportion of different clinical stages, imaging classification and gender between the 3-year survival of patients. Results Clinical stage II was the most with 20 cases (29.4%), stage IV was the least, solitary nodule imaging was 77.9%, muhi-nodular was 8.9%, invasive pneumococcal type was 13.2%, it had no difference between survival rates (P〉0.05).Conclusion Bronchioloalveolar carcinoma most occurs in women and non-smokers, early diagnosis is difficult, it has a high rate of 1 year survival.
出处 《中国中医药咨讯》 2011年第10期20-21,共2页
关键词 细支气管肺泡癌 临床特点 Bronchioloalveolar Carcinoma Clinical Characteristics
  • 相关文献

参考文献4

二级参考文献21

  • 1张晓彤,王淑兰,李龙芸.Gefitinib治疗晚期细支气管肺泡癌[J].中国医学科学院学报,2004,26(3):340-343. 被引量:3
  • 2王捷,曹梅生.吉西他滨加顺铂治疗弥漫性细支气管肺癌20例临床分析[J].浙江临床医学,2004,6(9):758-759. 被引量:5
  • 3潘启超.长春碱类的新进展──失碳长春碱[J].癌症,1996,15(3):228-231. 被引量:276
  • 4张鹏宇,金先桥.细支气管肺泡癌的诊断及治疗[J].国际肿瘤学杂志,2006,33(3):208-211. 被引量:8
  • 5[2]Grover FL,Piantadosi S.Recurrence and survival following resection of bronchioloalveolar carcinoma of the lung.Ann Surg,1989,209 (6):779-790.
  • 6[7]Depierre A,Jacoulet P,Garnier G.Efficacy of navelbine and vinca alkaloids in the treatment of non-small cell lung cancer.In:Pierre Fabre Oncologie,eds.Navelbine:update and new trends.Lst ed.France:John Libbty Eurotext Ltd,1991.133.
  • 7[2]Goodwin LO,Mason JM,Hajdu SI.Gene expression patterns of paired bronchioloalveolar carcinoma and benign lung tissue.Ann Clin Lab Sci,2001,31(4):369
  • 8[4]Furak J,Trojan I,Szoke T,et al.Bronchioloalveolar lung cancer:Occurrence,surgical treatment and survival.Eur Cardiothorac Surg,2003,23:818
  • 9[5]Volpino P,D Andrea N,Cangemi R,et al.Bronchioloalveolar carcinoma:Clinical,radiographic,and pathological findings.Surgical results.J Cardiovasc Surg (Torino),2001,42(2):261
  • 10[6]Roberts PF,Straznicka M,Lara PN.et al.Resection of multifocal non-small cell lung cancer when the bronchioloalveolar subtype is involved.J Thorac Cardiovasc Surg,2003,126:1597

共引文献15

同被引文献15

  • 1李易霞,吴重重,李智勇,伍建林.基于CT征象鉴别肺部磨玻璃结节良恶性的临床研究[J].中华临床医师杂志(电子版),2011,5(23):7151-7153. 被引量:14
  • 2Lee HY, Lee KS. Ground-glass opacity nodules : histopathology, imaging evaluation, and clinical implications [ J ] . J Thorac Imaging, 2011, 26 (2) : 106-118.
  • 3Park CM, Goo JM, Lee HJ, et al. Nodular ground-glass opacity at thin-section CT : histologic correlation and evaluation of change at follow-up [ J ] . Radiographics, 2007, 27 ( 2 ) : 391-408.
  • 4Fan L, Liu SY, Li QC, et al. Muhidetector CT features of pulmonary focal ground-glass opacity: differences between benign and malignant [J] .BrJRadiol, 2012,85 (1015) : 897-904.
  • 5Kim TJ, Goo JM, Lee KW, et al. Clinical, pathological and thin- section CT features of persistent multiple ground-glass opacity nodules : comparison with solitary ground-glass opacity nodule [ J ]. Lung Cancer, 2009, 64 (2) : 171-178.
  • 6Kim HY, Shim YM, Lee KS, et al. Persistent pulmonary nodular ground-glass opacity at thin-section CT : histopathologic comoarisons [ J ] . Radiology, 2007, 245 ( 1 ) : 267-275.
  • 7Ninomiya H, Hiramatsu M, Inamura K, et al. Correlation between morphology and EGFR mutations in lung adenocarcinomas Significance of the micropapillary pattern and the hobnail cell type[ J ]. Lung Cancer, 2009, 63 (2) : 235-240.
  • 8Kobayashi Y, Fukui T, Ito S, et al. How long should small lung lesions of ground-glass opacity be followed? [ J ] . J Thorac Oncol, 2013, 8 (3) : 309-314.
  • 9Miao XH, Yao YW, Yuan DM, et al. Prognostic value of the ratio of ground glass opacity on computed tomography in small lung adenocarcinoma : A meta-analysis [ J ] . J Thorac Dis, 2012, 4 (3) : 265-271.
  • 10Murakawa T, Konoeda C, Ito T, et al. The ground glass opacity component can be eliminated from the T-factor assessment of lung adenocarcinoma [ J ] . Eur J Cardiothorac Surg, 2013, 43 ( 5 ) : 925-932.

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部